Manufacturers to remove suicidal ideation warnings from Saxenda, Wegovy, and Zepbound labels following a large-scale FDA safety investigation.

A new commission will investigate the prevalence of SSRI antidepressants as adverse event reports document hundreds of cases of homicidal ideation and homicide. A newly released analysis of FDA ...

The U.S. Food and Drug Administration is now providing real-time, daily publication updates on adverse event data from its reporting system. In an effort to modernize and provide transparency on ...

The FDA announced that adverse event data from the FAERS will now be published daily. HealthDay News — The US Food and Drug Administration is now providing real-time, daily publication updates on ...

Please provide your email address to receive an email when new articles are posted on . The FDA Adverse Event Reporting System will now host daily publications, instead of quarterly. The agency’s goal ...

As Department of Health and Human Services (HHS) and FDA leadership continue to look for ways to boost transparency and reshape the U.S' healthcare infrastructure, the U.S. drug regulator has unveiled ...

The U.S. Food and Drug Administration said that it has begun the daily publication of adverse event reports related to drugs and biological products. This marks a shift from the previous quarterly ...

Last month, the US Food and Drug Administration (FDA) announced that it would begin daily publication of adverse event data for drugs and biologics via the FDA Adverse Event Reporting System (FAERS).

To increase transparency, the agency is publishing data from the FDA Adverse Event Reporting System daily rather than quarterly. (HealthDay News) — The U.S. Food and Drug Administration is now ...